Uncy stock price.

VRAX | Complete Virax Biolabs Group Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Uncy stock price. Things To Know About Uncy stock price.

Stock Inforamtion. IR Contacts. Company. Unicycive Therapeutics, Inc. 4300 El Camino Real Suite 210 Los Altos, CA 94022 T: 650-351-4495 [email protected]. Investor Relations. T: 650-543-5470 [email protected]. Transfer Agent. Philadelphia Stock Transfer, Inc. 2320 Haverford Road Ardmore, PA 19003. Email Alerts; Contacts; RSS ...Its stock benefits from rising oil prices as well, but it works to help tankers get their product onshore. ... UNCY) is a prototypical high-upside pharmaceutical stock in many senses.How much is Incyte stock worth today? ( NASDAQ: INCY) Incyte currently has 224,109,238 outstanding shares. With Incyte stock trading at $52.44 per share, the total value of Incyte stock (market capitalization) is $11.75B. Incyte stock was originally listed at a price of $22.50 in Dec 31, 1997.Union Pacific was founded in 1862 and is based in Omaha, Nebraska. The stock is a component of the S&P 500. The company has approximately 31,800 employees. Rating. Fair Value.

Unicycive Therapeutics (UNCY) H.C. Wainwright analyst Ed Arce maintained a Buy rating on Unicycive Therapeutics today and set a price target of $4.50.The company’s shares closed last Wednesday ...View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Find the latest Unicycive Therapeutics, Inc. (UNCY) stock quote, history, news and other vital information to help you with your stock trading and investing.Unicycive Therapeutics (UNCY) H.C. Wainwright analyst Ed Arce maintained a Buy rating on Unicycive Therapeutics today and set a price target of $4.50.The company’s shares closed last Wednesday ...

It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share.Unicycive Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time UNCY stock price.View the latest Unicycive Therapeutics Inc. (UNCY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Discover historical prices for GM stock on Yahoo Finance. View daily, weekly or monthly format back to when General Motors Company stock was issued.A high-level overview of Incyte Corporation (INCY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

6 mar 2023 ... UNCY Logo.jpg. Unicycive Announces up to $130 ... Shares of Series A Convertible Preferred Stock will be issued at a price of $1,000.00 per share.

Raymond kept his overweight rating and 100 price target on Incyte stock. Incyte's Outlook For 2023. For the year, Incyte guided to $2.55 billion to $2.63 billion in Jakafi sales and to $215 ...

Get historical data for the S&P 500 (^GSPC) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average ...Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the first quarter ended March 31, 2023 and provided a business update.If you don't see your stock on Nasdaq, it might have been delisted. ... Failure of a company to meet a minimum closing bid price of at least $1 for 30 consecutive trading days can trigger delisting.Get the latest Incyte Corporation (INCY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Find the latest Unicycive Therapeutics, Inc. (UNCY) stock quote, history, news and other vital information to help you with your stock trading and investing.Unicycive Therapeutics Third Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.37 loss in 3Q 2022) Unicycive Therapeutics ( NASDAQ:UNCY ) Third Quarter 2023 Results Key Financial Results Net ...

Discover historical prices for UNCY stock on Yahoo Finance. View daily, weekly or monthly format back to when Unicycive Therapeutics, Inc. stock was issued.View the latest Unicycive Therapeutics Inc. (UNCY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Shares of Series A Convertible Preferred Stock will be issued at a price of $1,000.00 per share. All of the shares of preferred stock, the warrants and the securities underlying such shares of ...Bionomics’ stock rallies 300% after company reports positive results in trial of PTSD treatment Sep. 28, 2023 at 10:59 a.m. ET by Ciara Linnane Bionomics started at buy with $7 stock price ...1 ene 2023 ... ... Price-Earnings Ratios and Implied Real Earnings Growth in Major Stock ... uncy, over. 80 percent of market participanL' accept l1.S. government se ...Find the latest Luckin Coffee Inc. (LKNCY) stock quote, history, news and other vital information to help you with your stock trading and investing.

View the latest AT&T Inc. (T) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Unicycive Therapeutics (UNCY) H.C. Wainwright analyst Ed Arce maintained a Buy rating on Unicycive Therapeutics today and set a price target of $4.50.The company’s shares closed last Wednesday ...Discover historical prices for GM stock on Yahoo Finance. View daily, weekly or monthly format back to when General Motors Company stock was issued.Find the latest BAIYU Holdings, Inc. (GLG) stock quote, history, news and other vital information to help you with your stock trading and investing.The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates.Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA. UNCY - Unicycive Therapeutics Inc - Stock screener for investors and traders, financial visualizations.When is Pieris Pharmaceuticals's earnings date? Pieris Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on PIRS's earnings history.View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.Price Unicycive Therapeutics, Inc. (UNCY) is a biopharmaceutical company that specializes in developing innovative treatments for rare and serious diseases. As of 2023, the company's stock price is $45.67 per share, with a market capitalization of $2.5 billion.0.43%. ¥27.63B. AI | Complete C3.ai Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Incyte is forecast to grow earnings and revenue by 30.9% and 10.8% per annum respectively. EPS is expected to grow by 30.3% per annum. Return on equity is forecast to be 21.9% in 3 years.

FE Battery Metals Corp (FEMFF) stock is trading at $0.51 as of 2:54 PM on Monday, Mar 6, a gain of $0.15, or 41.43% from the previous closing price of $0.36. Volume today is more active than usual. So far 2,448,699 shares have traded compared to average volume of 8,086 shares. The stock has traded between $0.41 and $0.53 so far today.

Key Data. Open $0.6450. Day Range 0.6053 - 0.7089. 52 Week Range 0.3950 - 1.4500. Market Cap $435.86M. Shares Outstanding 687.7M. Public Float 632.2M. Beta N/A. Rev. per Employee N/A.Latest 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or remove ads. Track Unicycive Therapeutics Inc (UNCY) Stock Price, Quote, latest …Share/Stock Market - LIVE BSE/NSE, Nifty Sensex Share Price, Stock Exchange, Top Gainers and Losers Stocks, Returns and Trading. Get Online Stock Trading News, Analysis on Equity and Stock Markets Tips, Sensex, Nifty, Commodities and more.Discover historical prices for UNCY stock on Yahoo Finance. View daily, weekly or monthly format back to when Unicycive Therapeutics, Inc. stock was issued. UNCY Price Action: Unicycive shares are nearing new 52-week highs after more than tripling in early trading. The stock was up 220.6% at $1.57 at time of publication, ...122.11. -4.39%. 1.02M. Find the latest Unicycive Therapeutics Inc (UNCY) stock forecast, 12-month price target, predictions and analyst recommendations.Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are ...Nov 29, 2023 · See the latest Incyte Corp stock price (INCY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Unicycive Therapeutics Stock Down 2.5 % Shares of UNCY stock opened at $0.49 on Friday. The firm has a market cap of $17.03 million, a price-to-earnings ratio of -0.28 and a beta of 2.26.News Unicycive Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.73 Market Cap $18.77 M Shares Outstanding 34.75 M Public Float... Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by …0.4900 -0.0225 (-4.39%) At close: 03:59PM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced from all markets Gain actionable insight from technical analysis on financial...

The average price point forecasted by analysts for Unicycive Therapeutics Inc (UNCY) is $4.50, which is $3.92 above the current market price. The public float for UNCY is 24.98M, and currently, short sellers hold a 0.25% ratio of that float. The average trading volume of UNCY on November 23, 2023 was 51.38K shares.Find the latest Adaptive Biotechnologies Corporation (ADPT) stock quote, history, news and other vital information to help you with your stock trading and investing.The stock market index granted WiSA the customary 180-day period to regain compliance by reaching the necessary share price. While it failed to reach it by Jan. 18, 2023, the company responded by ...Instagram:https://instagram. gold highest priceameritrade day tradesis spacex going publicbeta in stocks meaning According to the issued ratings of 4 analysts in the last year, the consensus rating for Unicycive Therapeutics stock is Buy based on the current 4 buy ratings for UNCY. The average twelve-month price prediction for Unicycive Therapeutics is $10.83 with a high price target of $24.00 and a low price target of $4.00. good day trading platformssagafalabela Find the latest HUB Cyber Security Ltd. (HUBC) stock quote, history, news and other vital information to help you with your stock trading and investing. wallsteetbets View the latest AT&T Inc. (T) stock price, news, historical charts, analyst ratings and financial information from WSJ.8 left in stock +3; Brand Name Salty Crew Product Name Lineup 21" Boardshorts Color Plum Price. $67.95. Rating. Hurley - Phantom-Eco Block Party 18" Boardshorts. ... Price. $39.20 MSRP: $98.00. Rating. Billabong - 73 Pro 20" Boardshorts. Color Blue Haze. Low Stock. $59.90. 9 left in stock +5; Brand Name Billabong Product Name 73 Pro 20" …